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Children raised in orphanages frequently experience growth suppression due to multiple risk factors. Placing such children in
more nurturing environments through adoption leads to signiﬁcant catch-up growth (CUG), the determinants of which are not
entirely understood. The goal of this study was to perform an auxological evaluation and examine the degree and correlates of
CUG in international adoptees. Children adopted from Eastern Europe, (n = 148, 71 males), 7 to 59 months of age, were recruited
within 3 weeks of their arrival to the US. At baseline, mean height SDS was −1.2 ± 1.1 and 22% were <−2S D Sf o rh e i g h t .I G F -
1a n d / o rI G F B P - 3l e v e l s<−2 SDS were present in 32%. CUG, deﬁned as a gain of >+0.5 in height SDS, was seen in 62% of
adoptees at 6 months after adoption; 7% of children remained <−2 SDS for height (two had growth hormone deﬁciency). Growth
factors improved in the majority of children. Younger age, greater degree of initial growth failure, and higher caloric intake were
signiﬁcantly associated with improved linear growth in multiple regression models. In summary, most adoptees demonstrate
excellent CUG within six months after adoption. If growth failure persists after 6 months of appropriate caloric intake, nutrition-
independent causes should be considered.
1.Introduction
Since 2000, over 160,000 children have come to the United
States as international adoptees [1]. More than 25% of these
children have come from Eastern European countries having
received primarily institutional care. Children in these
orphanages frequently endure signiﬁcant social deprivation
that may impact their physical growth due to suppression of
hypothalamic function with consequent low levels of growth
factors [2]. We and others have previously documented sig-
niﬁcant physical growth delays in up to 34% of international
adoptees from Eastern Europe, South America, and Asia [3–
5]. Of the many hereditary, environmental, and hormonal
factors that may contribute, we have previously shown that
age, prenatal factors (birth weight and risk of fetal alcohol
syndrome), and growth factors (Insulin-like Growth Factor
Binding Protein-3, IGFBP-3) are independently associated
with the degree of growth delay in adoptees upon arrival into
the US [4].
A rapid period of catch-up growth (CUG) is seen
following a variety of growth delays when the causative
conditions improve. The Growth Hormone-(GH-)Insulin-
like Growth Factor (IGF) system is known to be involved in
CUGfollowingmanycausesofgrowthdelay,butlimiteddata
are available on the role of GH-IGF system in CUG following
adoption [6]. The goal of this prospective longitudinal2 International Journal of Pediatric Endocrinology
Table 1: Characteristics of international adoptees upon arrival to USA and after 6 months.
Arrival 6 months
n Mean ± SD % <−2S D S n Mean ±SD % <−2S D S
Age 148 20.1 ±9.76 N/A 132 26.4 ±10.2N / A
Gender 148 77F 71M 48.0c 132 68F 64M 48.5c
Height SDS 148 −1.22 ±1.07 21.6 132 −0.58 ±0.99
∗ 6.8∗
Weight SDS 148 −1.44 ±1.30 33.8 132 −0.62 ±1.13
∗ 9.8∗
Wt for Ht SDS 148 −0.45 ±1.24 9.5 132 −0.10 ±1.14
∗ 4.5∗
OFC SDS 148 −0.65 ±1.13 12.2 130 −0.26 ±1.24
∗ 8.5∗
IGF-1 SDS 133 −1.13 ±1.42 27.8 124 −0.95 ±1.34 22.6
BP-3 SDS 136 −0.92 ±1.10 12.5 124 −0.52 ±1.03
∗ 5.6∗
Dietary intakea 115 108 ±33 N/A 111 125 ±34
∗ N/A
%DRIb 102 135 ±42 N/A 103 157 ±42
∗ N/A
BW (kg) 104 2.75 ±0.71 32.7d
aKcal/kg; b%Dietary reference Intake; cPercent male; dBW <2.50 kg; ∗P<. 05.
∗
∗
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Figure 1: Characteristics of international adoptees upon arrival
to USA and after 6 months. Standard Deviation Scores (SDSs)
for height (Ht), weight (Wt), weight for height (Wt/Ht), occipito-
frontal circumference (OFC), IGF-1, and BP-3 values at arrival
(open bars) and after 6 months (shaded bars). ∗P<. 05.
study was to examine the determinants of CUG in 148
postinstitutionalizedinternationaladopteesduringtheﬁrst6
monthsafterarrivalintotheiradoptivefamilies.Weaimedto
identify baseline factors that would help predict subsequent
CUG and therefore help counsel the families, the degree of
CUG, the usefulness of obtaining IGF-I and IGFBP-3 levels,
and the impact of nutrition on CUG and the physiologic
roles of nutrition and the growth hormone system on CUG.
2. Patientsand Methods
2.1. Participants. Participants were part of a longitudinal
study of growth of institutionalized children adopted into
the USA from Eastern Europe (Russia, Kazakhstan, and
Ukraine). The study was approved by the Institutional
Review Boards of the University of Minnesota and Inova
Fairfax Hospital for Children, and written informed consent
was obtained from the adoptive parents. Participants who
were between 6 and 59 months of age at adoption were
recruited and enrolled through the International Adoption
Clinics at the University of Minnesota and Inova Fairfax
Hospital for Children between March 2004 and March 2007.
2.2. Study Design. Participants were examined within three
weeks of arrival into the USA and then six months later.
Auxological parameters included length or height (aver-
age of triplicate measurements), single determinations of
weight, and occipitofrontal circumference (OFC). Midarm
circumference, triceps, and subscapular skinfolds were also
measured to assess the nutritional status of the adoptees in
addition to liver function tests, total protein, and albumin,
which are part of a routine pre-adoption evaluation. Pread-
option historical data, including birth weight (BW) and time
spent in institutions, such as hospitals and orphanages, were
obtained via parent interview and translated pre-adoption
medical records provided by the adoptive parents. Children
wereclassiﬁedasbeingathighriskforfetalalcoholsyndrome
(FAS) if a moderate or severe facial phenotype was identiﬁed
using facial photographic analysis software as previously
described [7–10]. Dietary information was collected via
a three-day diet record at each visit. Mothers recorded
everything the child ate for three separate days in the two
weeks prior to the clinic visit. The diet records were reviewed
for completeness, and mothers were contacted afterward
for additional clariﬁcation, if necessary. The diet records
were entered into the Nutrition Data System for Research
software (University of Minnesota) that generates intakes for
160 nutrients averaged over the three-day period of intake.
Percentage of the US Dietary Reference Intakes (DRIs)
were calculated using recommendations of the Institute of
Medicine [11]. The DRI represents caloric requirements of a
healthy child of a given age. If a child is receiving appropriate
nutrition, the %DRI is 100%.
2.3. Biochemical Assays. Serum (2.5ml) was obtained
through venipuncture and stored at −20
◦C until shipping.
IGF-1 and IGFBP-3 were quantiﬁed by radioimmunoassay
performed by Esoterix, Inc. (Calabasas, CA) and reported
as actual values and Standard Deviation Scores (SDSs)
[12]. TSH was measured by commercial chemiluminescent
immunoassay as part of routine care. TSH was deﬁned
as high if it was above the normal range of the assay
(≥5.0μIU/mL).International Journal of Pediatric Endocrinology 3
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Figure 2: Age dependence of catch-up height velocity. Large panel: the height velocity (cm/y) at 6 months is plotted against age with
normative reference data for 50th and 95th percentiles. Left inset: height velocity based upon age category. Right inset: percentage achieving
height velocity >10, 15, and 20cm/y.
Table 2: Independent predictors of auxological change.
Delta Ht SDS Delta Wt SDS Delta OFC SDS
Variables at baseline Coeﬃcient P Coeﬃcient P Coeﬃcient P
Age (months) −0.014 .001∗ −0.005 .574 −0.006 .653
Gender 0.063 .439 −0.154 .384 0.487 .082
Height SDS −0.143 .001∗ N/A 0.424 .017∗
BP-3 SDS −0.139 .142 −0.918 .038∗ N/A
IGF-1 SDS −0.038 .682 N/A N/A
Dietary intake (Kcal/kg) 0.300 .031∗ 0.009 .002∗ N/A
Weight SDS N/A −0.478 .000∗ N/A
BW (kg) N/A 0.548 .000∗ N/A
OFC SDS N/A N/A −0.407 .001∗
∗P<. 05.
2.4. Data Analyses. Age- and gender-speciﬁc Z scores for
anthropometric variables were calculated based on the CDC
2000 Growth Charts using Epi Info 3.3 (Centers for Disease
Control and Prevention, Atlanta, GA). For children older
than 36 months, OFC SDS was estimated from the data
of Roche et al. [13]. Age-speciﬁc percentiles for estimated
annual height velocity were estimated from the ﬁgures and
tables of Roche and Himes [14]. Statistical calculations and
modeling were performed using SPSS software (SPSS, Inc.,
Chicago, IL). Analyses were conducted on all subjects that
had complete data for that analysis, and the numbers of
available cases are reported, accordingly. Changes in mean
growth variables within the same individuals were evaluated
using paired t-tests, and tests among multiple means for
independent groups were by analysis of variance. Linear
regression models for growth status and change were devel-
opedbyconsideringonlythesubsetofpotentialindependent
variables whose Spearman correlation coeﬃcients with the
dependent variables were statistically signiﬁcant at P ≤
.10. Age and gender were included in all regression models
irrespective of statistical signiﬁcance. Partial regression coef-
ﬁcients were considered statistically signiﬁcant at P<. 05.4 International Journal of Pediatric Endocrinology
Interactions among independent variables were investigated
a n dr e j e c t e da tP>. 10. Adjusted odds ratios describing
associations of tertiles of Kcal/kg, IGF-1, and IGFBP-3
with subsequent CUG were estimated from logistic regres-
sions using CUG (≥0.5 SD) as a dichotomous-dependent
variable and adjusting for gender, age, and high risk for FAS
status.
3. Results
The mean age at the time of initial evaluation was 20
months (range 7–59 months), which was on average 20 ±
10 days after arrival into the USA (Table 1). The follow-
up appointment was a mean of 6.05 ± 0.86 months later.
As we have previously reported, international adoptees had
signiﬁcant growth failure upon arrival, which was more
severe in children with low birth weight (LBW, <2500g; n =
34/104,32.7%)andhighriskforFAS(n = 10/132,7.6%)[4].
All three growth parameters were aﬀected; 22% of children
were<−2SDSforheight,34%were<−2SDSforweight,and
12% were <−2 SDS for OFC. Ten percent of children were
wasted at baseline using weight-for-height <−2S D S .L o w
IGF -1and/orIGFBP -3lev els(<−2SDS)werepresentin32%
(44 out of 136) at the initial visit. Liver function tests, total
protein, and albumin were normal. At baseline, the mid-arm
circumference was slightly below average when normalized
for age (−0.73 SDS, 12.4% < − 2 SDS) and height (−0.56
SDS, 10.8% <−2 SDS), and the weight for height was near
normal(−0.45±1.24SDSwith9.5%below −2SDS,Table 1).
At 6 months, there was signiﬁcant improvement in
means for height SDS, weight SDS, OFC SDS, weight for
height SDS, and IGFBP-3 SDS (P<. 05) (Table 1, Figure 1).
The change in IGF-I was not statistically signiﬁcant. CUG,
deﬁned as a gain of >+0.5 in height SDS, was observed in
62% of children (82 out of 132), and 23% (30 out of 132)
gained >+ 1 height SDS over the six month period.
84% of children had height velocity greater than the 50th
percentile for age with 55% greater than the 95th percentile
(Figure 2). 90% of children had height velocity >10cm/yr
and 12% >2 0c m / y r .T h ed e g r e eo fC U Gw a sa g ed e p e n d e n t
with mean growth velocities for children <18 months =
16.9 ± 3.6cm/yr, 18–30 months = 12.8 ± 3.0cm/yr ,and
>30 months = 10.6 ± 2.5cm/yr (P<. 001) (Figure 2).
Although the proportion of stunted children signiﬁcantly
decreased by 6 months, 6.8% of children (N = 132)
remainedbelow−2SDSforheight,9.8%forweight,8.5%for
head circumference, and 4.5% for weight for height. Despite
signiﬁcant CUG in the group as a whole, IGF-1 and/or
IGFBP-3 remained low in a signiﬁcant number of children
(23% <−2 SDS) (29 out of 124).
In order to identify potential factors associated with
CUG, we examined the relationships of the change in
auxological parameters and growth factors with a number of
environmental, historical, physical, medical, and hormonal
variables. Young age, severity of short stature, and higher
dietary intake at the initial visit were statistically signiﬁcant
independent predictors of improved growth (delta Ht SDS)
(Table 2). Neither IGF-I nor IGFBP-3 SDS was an inde-
pendent predictor of delta Ht SDS. Also, children in the
lowest tertile of IGF-1 SDS were signiﬁcantly more likely
to show height CUG than those in the highest tertile (P =
.042, OR = 4.9, 95%CI: 1.1–22.9). Although associated
with baseline growth failure, LBW and being at high risk
for FAS were not signiﬁcant predictors of CUG in height.
However, low risk for FAS children was more likely to
show height CUG than the high risk for FAS children
(P = .007, OR = 34.8, 95%CI: 2.7–457.6). Excluding high
risk for FAS children from the regression analysis did not
change the signiﬁcant predictors. Mid-arm circumference
and baseline weight for height were not independently
predictive of baseline height SDS or degree of height
CUG.
Because of the important role of nutrition in growth, we
analyzed caloric intake at baseline and six months using a
three-day diet record. Mean caloric intake was higher than
the DRI at arrival (%DRI = 135 ± 42; Kcal/kg = 108 ± 33)
and was increased further at six months (%DRI = 157 ± 42;
Kcal/kg = 125 ± 34; P<. 001) (Table 1). At baseline, 76%
of children were consuming greater than the DRI (100%)
increasing to 93% at six months. Although mean height
velocity was higher in younger children (Figure 2) and in
thosewithhighercaloricintake (Table 2),themeanincreases
in caloric intake per kg did not signiﬁcantly diﬀer across
diﬀerent ages (P>. 3b yA N O V A )( Figure 3).
Those children who had CUG (gain in height > +0.5
SDS) had statistically signiﬁcantly higher caloric intake
at both baseline and 6 months (Table 3) compared with
other children. Caloric intake at 6 months was signiﬁcantly
correlated with subsequent change in height SDS (r = 0.318,
P = .001). Children in the highest tertile of caloric intake/kg
at the initial visit were also signiﬁcantly more likely to show
height CUG than those in the lowest tertile of Kcal/kg
(P = .033, OR = 4.2, 95%CI: 1.1–15.9). Relatively lower
baseline weight SDS, higher birth weights, higher caloric
intake, and lower baseline IGFBP-3 SDS were signiﬁcant
positive independent predictors of change in weight SDS
(Table 2). Caloric intake at 6 months was also signiﬁcantly
correlated with the change in weight SDS (r = 0.441,
P<. 001) over the 6-month interval. OFC SDS and Ht
SDS were independent predictors of growth in OFC, so that
children with relatively smaller heads and greater heights
at baseline had the most improvement in subsequent head
growth (Table 2). If children who were high risk for FAS
were excluded from the analysis, Ht SDS was no longer
a signiﬁcant independent predictor of subsequent OFC
growth.
Nine children (6.8%) remained stunted (height <−2
SDS) at the 6-month follow-up. Children who remained
stunted were signiﬁcantly older (mean 32 months, range 14
to 59), shorter (mean −3.1 Ht SDS, range −2.1 to −4.1),
lighter (mean −2.5 Wt SDS, range −1.4 to −4.0) and had
smaller heads (mean −1.66 OFC SDS, range −3 . 3t o2 )a tt h e
time of adoption than those who caught up (Table 4). There
were no signiﬁcant diﬀerences in mean baseline growth
factors in those who remained stunted compared to those
who caught up. Three of the children who had high risk for
FAS remained stunted at 6 months. However, the degree of
height CUG (delta Ht SDS) in high risk for FAS childrenInternational Journal of Pediatric Endocrinology 5
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Figure 3: Dietary intake upon arrival to USA and after 6 months. Dietary intake for age expressed as kcal/kg (a and b) and %DRI (c and d)
at baseline (a and c) and after 6 months (b and d). The %DRI age reference (100%) is indicated by a line (c and d).
Table 3: Dietary intake and catch-up growth.
<+0.5 Ht SDS (No CUG) >+0.5 Ht SDS (+ CUG) P
Baseline (Kcal/kg) 98 ± 30 (n = 36) 114 ± 34 (n = 68) .021∗
6 months (Kcal/kg) 115 ± 34 (n = 37) 129 ± 32 (n = 71) .039∗
Baseline (%DRI
a) 122 ± 38 (n = 35) 142 ± 43 (n = 67) .018∗
6m o n t h s( % D R I
a) 143 ± 46 (n = 33) 163 ± 39 (n = 70) .029∗
a%Dietary reference intake; ∗P<. 05.
wasnotstatisticallydiﬀerentfromthelargercohort(data not
shown).
Due to persistent short stature, children who did not
catch-up by 6 months (n = 6) were referred for pedi-
atric endocrinology evaluation. At the time of endocrine
evaluation, ﬁve of these children had shown further CUG
and were taller than −2 Ht SDS. Among the four children
who remained stunted, two were identiﬁed by provocative
growth hormone stimulation testing as having growth
hormone deﬁciency. One female child with growth hormone
deﬁciency, who was adopted at 14 months old and had
associatedopticnervehypoplasiaandFAS,hasdemonstrated
an excellent response to growth hormone therapy with
height at the 25th percentile at last evaluation ﬁve years after
adoption. The pretreatment growth velocity was 6.8cm/year
(GV SD not established) compared to 12.3cm/year (+2.96
SD) after 1 year of treatment with growth hormone. The
other child a male who was 4 years old at the time of6 International Journal of Pediatric Endocrinology
Table 4: Baseline characteristics of children who remained stunted versus those who caught up after 6 months.
Baseline Ht < −2 SDS Ht > −2 SDS(caught-up) P
Height SDS −3.10 ±0.69 (n = 9) −1.10 ±0.98 (n = 134) .000∗
Weight SDS −2.53 ±0.81 (n = 9) −1.37 ±1.31 (n = 134) .010∗
OFC SDS −1.66 ±1.60 (n = 9) −0.61 ±1.08 (n = 134) .007∗
IGF-1 SDS −1.75 ±1.97 (n = 8) −1.10 ±1.40 (n = 121) .216
BP-3 SDS −1.13 ± 1.48 (n = 8) −0.89 ± 1.08 (n = 124) .529
Age (months) 32.0 ±13.7( n = 9) 19.3 ±9.1( n = 134) .000∗
Dietary intake (Kcal/kg) 109 ±23 (n = 9) 109 ±34 (n = 105) .975
∗P<. 05.
adoption with growth hormone deﬁciency was at low risk
for FAS and also demonstrated a good response to growth
hormone treatment. The pre-treatment growth velocity was
4.9cm/year (−0.82 SD) compared to 6.9cm/year (+2.12 SD)
after 1 year of treatment with growth hormone. He is now
growing along the 5th percentile at last evaluation on growth
hormone therapy ﬁve years after adoption.
Elevated TSH (>5 μIU/ml, range 5.06–11.60) was seen in
international adoptees (n = 18/110, 16.4%) at baseline with
a normal free T4 level. Of the 18 children with elevated TSH
at baseline, 6 had normal TSH at the 6-month follow-up, 7
had no follow-up TSH reported, and 5 had elevated TSH at
the end of the study. Children with elevated TSH at the end
of the study (n = 5/110, 4.5%) were referred to a pediatric
endocrinologist.
4. Discussion
In this prospective study of CUG in children following
international adoption, we found that signiﬁcant growth
failure was present at baseline as published before by the
authors [4]. During the ﬁrst 6 months after adoption, these
children experienced substantial CUG in length, weight,
and OFC similar to previous cohorts [15, 16], and the
degree of CUG positively correlated with the young age and
the time of adoption as observed by others [5]. However,
more than a third of children in this study did not show
signiﬁcant CUG (>+0.5 SDS) during the 6-month follow-
up period. 6.8% of children remained stunted (<−2H t
SDS) at the end of the study, and two of these children
were identiﬁed as having growth hormone deﬁciency. Older
children with more severe baseline growth failure were
more likely to remain stunted at follow-up. Although our
previous analyses showed that LBW, high risk for FAS, and
IGFBP-3 were signiﬁcantly and independently associated
with height SDS at the time of adoption [4], these variables
were not signiﬁcant independent predictors of subsequent
height CUG, which in the case of IGFBP-3 was likely due
to its correlation and colinearity with baseline Ht SDS [4].
Changes in IGF-1 and IGFBP-3 were positively correlated
with linear growth, but were not independent predictors of
growth restoration of adoptees. Therefore, it is likely that
the improved nutrition and other changes, such as a more
nurturing environment, have an important eﬀect on the
growth hormone axis inﬂuencing catch-up growth. Among
the variables analyzed, only age, caloric intake (per kg), and
baseline height were found to be independent predictors of
height CUG.
Previous studies of CUG following growth failure caused
by other mechanisms have shown improvement in serum
levels of components of the GH-IGF system [17, 18].
However, limited data are available on the role of GH-
IGF system in CUG following adoption [6]. We found that
although baseline serum IGFBP-3 values correlated with the
degree of linear growth failure [4] and IGF-1 and IGFBP-
3 SDS values improved in most children, neither IGFBP-3
nor IGF-1 was predictive of the degree of height CUG in
the ﬁrst six months following adoption. The ﬁnding that
neither baseline growth factor levels nor the change in their
values independently predicted the degree of CUG in height
was unexpected. There are several potential explanations.
It is possible that rapid changes in IGF-1 levels could
have occurred between the time that these children were
united with their adoptive parents and when the IGF-
1 values were measured in the clinic. This improvement
could be related to improved nutrition or improved growth
hormone secretion. Alternatively, low levels of IGFBP-3 may
primarily reﬂect baseline growth hormone status in some
patients. Improvement in IGFBP-3 over time may improve
the delivery of IGF-1 to the target tissue. Finally, it is possible
that other related factors, such as baseline height or caloric
intake, are more important than these growth factors in this
early, rapid CUG phase. Each of these possibilities requires
further evaluation. These relationships suggest that although
growth factors improve during this period, recovery from
growth failure related to international adoption is a complex
phenomenon that is dependent upon a number of factors
and not solely related to restoration of normal function of
the GH-IGF system per se.
Growth failure at the time of international adoption
could represent a combination of malnutrition, reduced
growth hormone secretion, and/or growth hormone resis-
tance as observed in other conditions. For example, chil-
dren who suﬀer from intrauterine growth retardation
have been shown to have growth hormone resistance, but
normal growth hormone production [19]. In psychoso-
cial short stature, both growth hormone-responsive and
growth hormone-resistant forms have been described [20].
Reversible suppression of growth hormone secretion may
also occur in hyperphagic short stature, which is a conditionInternational Journal of Pediatric Endocrinology 7
associated with disordered eating behaviors (stealing food,
hoarding food, foraging for discarded food) that are com-
monly seen in institutional settings [21, 22].
Access to suﬃcient macro- and micronutrients to sup-
port growth is critically important and, worldwide, the
most common cause of growth failure during childhood.
Nutritional demands vary depending on growth rates at
diﬀerent stages of development and any preexisting deﬁcits
due to pre- or postnatal malnutrition. During the most rapid
growth phase between birth and 18 months the eﬀects of
even modest nutritional deﬁcits may become magniﬁed in
children within institutional care settings. In this study, we
found that 10% of the children were wasted (Wt <−2 SDS)
on arrival that relative caloric intake was unusually high at
baseline and substantially increased in most children. The
degree of CUG for height and weight was related to calorie
intake both at arrival and at six months. In addition, we
have previously shown a high incidence of iron deﬁciency at
adoptionthatpersistsatsixmonthsdespiteironintakethatis
abovetherecommendeddailyallowance[23].Theseﬁndings
emphasize the role of adequate nutrition support for CUG
in international adoptees and highlight the need to monitor
feeding issues that could impact nutritional intake.
5. Conclusions
We found that the growth hormone axis, as measured by
IGF-1 and IGFBP-3, may be suppressed at baseline following
international adoption. Growth factors improve during the
6-month interval after adoption in the majority of children.
Baseline IGFBP-3 is an independent predictor of weight
CUG,butnotheightCUG.Ageandseverityofgrowthfailure
at the time of adoption are independent predictors of the
degree of subsequent CUG. LBW and high risk for FAS,
associated with baseline growth failure, are not signiﬁcant
predictors of the degree of subsequent CUG, although a
third of children who remained stunted after six months had
facial features suggestive of FAS. Caloric intake is related to
the degree of CUG for height and weight. As nutritional
intervention appears to be extremely important during the
ﬁrst 6 months after adoption, we recommend that adoptive
parents be made aware of the need for increased calories
beyond typical age requirements. If growth failure persists
after 6 months of appropriate caloric intake, nutrition-
independent causes should be considered, for example,
growth hormone deﬁciency. The older, the more severely
stunted at the time of adoption, and those who are high risk
for FAS should be monitored most closely.
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